(Reuters) - Pfizer Inc <PFE.N> is exploring sale of a group of treatments in cardiology, urology and primary care, Bloomberg reported on Thursday, citing people familiar with the matter.

The drugs could fetch more than $2 billion, Bloomberg reported. (

Pfizer is working with financial adviser JPMorgan Chase & Co for the potential portfolio sale and the process is at a preliminary stage, Bloomberg said.

Pfizer could not be immediately reached for comment.


(Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Savio D'Souza)

Most Popular From ...